Analysis reveals high levels of vancomycin-resistant enterococci in Guilan's recreational waters, suggesting public health risks.
This study characterizes vancomycin-resistant Enterococci (VRE) in Iran's Anzali Lagoon recreational waters through analysis of 268 samples collected seasonally (2019). Culture and PCR methods identified Enterococcus in 57.5% (154/268) of samples, with 40.3% (62/154) showing vancomycin resistance. Resistance gene profiling revealed vanA and vanH predominance (56.5% each, 35/62), demonstrating complete co-occurrence, while vanB was rare (3.2%, 2/62) and vanC absent. Virulence factors displayed divergent prevalence: esp (62.9%, 39/62) exceeded clinical isolate rates, whereas hyl (3.2%, 2/62) was uncommon. Biofilm assays showed VRE isolates formed significantly denser biofilms than susceptible strains (2.3-fold higher OD570, p < 0.001), with esp-positive isolates exhibiting the strongest biofilm production. These findings demonstrate that recreational waters harbor VRE populations with: (1) elevated esp prevalence suggesting environmental selection pressures, and (2) enhanced biofilm capacity promoting persistence. The 100% vanA-vanH co-occurrence and 62.9% esp frequency surpass WHO risk thresholds for recreational waters, indicating need for revised monitoring protocols. This study provides the first evidence of aquatic-specific VRE genotypes in the region and their potential public health impacts through resistance gene dissemination and waterborne exposure risks.
No takes yet. Share an insight, caveat, or question.
Kalantari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: